Every figure this model derived for XRAY, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 176,000,000 | PaymentsToAcquireProductiveAssets |
2026-06-30 |
| cash | 239,037,000 | CashAndCashEquivalentsAtCarryingValue |
2026-06-30 |
| current assets | 1,928,000,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 1,185,000,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 1,351,000,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 91,000,000 | InterestExpenseNonoperating |
2026-06-30 |
| ocf | 319,000,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 3,643,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 31,000,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up XRAY on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 1.92 |
| current ratio | 1.73 |
| current ratio reported | 1.63 |
| deferred revenue growth | -34.86 |
| dilution pct | -1.87 |
| ev owner earnings | 39.87 |
| ev sales | 1.23 |
| fcf margin | 3.93 |
| growth cv | 4.68 |
| interest cover | -3.41 |
| net debt ebitda | 58.08 |
| operating margin | -8.51 |
| owner earnings margin | 3.07 |
| revenue growth | -0.76 |
| revenue growth per share | 1.13 |
| roic | -6.77 |
| rule of 40 | -9.27 |
| sbc pct revenue | 0.85 |
What this model itself distrusts about XRAY's figures. Written by the derivation as it ran, not added afterwards.